Sektor DaShenLin Pharmaceutical Group Co., Ltd.
Aktien
A2N318
CNE100002RG2
603233
Handel - Medikamente
|
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 15.87 CNY | -1.73% |
|
-4.86% | -9.93% |
| 24.04. | Dashenlin Pharma: Gewinn klettert im ersten Quartal um 11% | MT |
| 24.04. | Dashenlin Pharma: Gewinn springt 2025 um 35% nach oben, Umsatz steigt um 4% | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.73% | -4.86% | -8.16% | -12.37% | -9.93% | -0.50% | -43.28% | -55.30% | - | 2.67 Mrd. | ||
| -2.01% | -9.34% | -16.20% | -29.33% | -40.18% | -16.37% | -30.18% | -68.56% | - | 13.8 Mrd. | ||
| 0.00% | -4.37% | -13.23% | -30.21% | -35.05% | -24.60% | -26.62% | -80.73% | -41.43% | 6.76 Mrd. | ||
| -0.84% | -0.96% | +4.57% | -3.14% | -14.82% | -21.31% | -14.22% | +39.30% | +166.54% | 5.68 Mrd. | ||
| -0.75% | -5.55% | -4.91% | -19.22% | -9.07% | -16.06% | -37.15% | -40.32% | +101.70% | 3.54 Mrd. | ||
| -1.75% | +2.00% | -3.01% | -18.11% | -29.08% | -34.07% | -9.21% | -1.41% | +101.83% | 3.41 Mrd. | ||
| -0.47% | -2.11% | -3.05% | -6.62% | +0.26% | -24.28% | -44.10% | - | - | 3.31 Mrd. | ||
| -4.20% | -4.67% | +4.79% | +8.53% | +34.40% | +99.02% | - | - | - | 2.65 Mrd. | ||
| +0.15% | -4.36% | -6.32% | -9.58% | -18.46% | -16.82% | -2.59% | +41.36% | +105.27% | 2.48 Mrd. | ||
| +1.44% | +3.13% | -5.39% | +2.52% | -1.11% | +9.25% | +47.84% | +8.77% | - | 1.81 Mrd. | ||
| +1.62% | +10.12% | +48.96% | +108.69% | +3.61% | -26.44% | -24.15% | -56.98% | - | 1.53 Mrd. | ||
| +0.52% | +2.11% | +4.30% | +13.12% | +36.18% | +72.86% | +115.72% | +212.80% | +328.92% | 1.17 Mrd. | ||
| -0.03% | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -8.57% | +2.85% | 1.14 Mrd. | ||
| +0.35% | -3.76% | -6.77% | +4.82% | +3.58% | -3.96% | +6.80% | - | - | 1.06 Mrd. | ||
| -1.19% | -1.46% | -10.43% | -14.95% | -13.59% | -42.51% | -57.22% | - | - | 988 Mio. | ||
| -0.39% | -2.67% | -14.21% | -10.61% | -17.40% | +31.70% | -9.98% | - | - | 905 Mio. | ||
| -0.84% | -5.43% | -9.39% | -16.51% | -17.42% | -33.54% | -60.18% | -68.93% | -52.59% | 900 Mio. | ||
| +2.12% | +0.54% | -4.05% | +31.81% | -19.16% | -14.80% | - | - | - | 793 Mio. | ||
| -0.08% | -1.80% | -3.04% | -5.28% | -11.25% | +12.55% | -26.75% | - | - | 784 Mio. | ||
| +4.09% | -3.36% | -4.06% | -12.91% | -33.37% | -9.70% | +51.26% | +76.97% | - | 600 Mio. | ||
| Durchschnitt | -0.20% | -1.61% | -2.48% | -0.97% | -9.59% | -2.98% | -9.11% | -0.12% | +89.14% | 2.8 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.90% | -3.84% | -5.83% | -11.57% | -18.33% | -9.66% | -19.52% | -28.77% | +78.75% |
- Börse
- Aktien
- A2N318 Aktie
- Sektor DaShenLin Pharmaceutical Group Co., Ltd.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















